Skip to main navigation Skip to search Skip to main content

Body composition as a predictor of chemotherapy toxicity in patients with metastatic prostate cancer treated with docetaxel

Research output: Contribution to journalArticlepeer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Docetaxel
  • Prostate cancer
  • Oncology
  • Toxicity
  • Medicine
  • Chemotherapy
  • Internal medicine
  • Cancer

Cite this